Effect of STING agonist on tumor immune microenvironment of non-inflamed lung cancer and efficacy of immune checkpoint blockade.

被引：3
|
作者：
Chon, Hongjae [1 ]
机构：
[1] CHA Hosp, Seongnam, South Korea
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 05期
关键词：
D O I：
10.1200/JCO.2018.36.5_suppl.178
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
178
引用
收藏
页数：1
相关论文
共 50 条
  • [21] STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
    Jing, Weiqing
    McAllister, Donna
    Vonderhaar, Emily P.
    Palen, Katie
    Riese, Matthew J.
    Gershan, Jill
    Johnson, Bryon D.
    Dwinell, Michael B.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2019, 7
  • [22] Clinical outcomes of patients with non-small cell lung cancer (NSCLC) receiving chemotherapy after immune checkpoint blockade.
    Grigg, Claud
    Reuland, Brian D.
    Sacher, Adrian G.
    Yeh, Randy
    Rizvi, Naiyer A.
    Shu, Catherine A.
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35
  • [23] Effect of mesenchymal-epithelial transition amplification on immune microenvironment and efficacy of immune checkpoint inhibitors in patients with non-small cell lung cancer
    Su, Shan
    Lin, Anqi
    Luo, Peng
    Zou, Jianjun
    Huang, Zhihao
    Wang, Xiaojun
    Zeng, Yunyun
    Cen, Wenchang
    Zhang, Xianlan
    Huang, Huiyi
    Hu, Jinxing
    Zhang, Jian
    ANNALS OF TRANSLATIONAL MEDICINE, 2021, 9 (18)
  • [24] The Tumor Microenvironment Factors That Promote Resistance to Immune Checkpoint Blockade Therapy
    Russell, Bonnie L.
    Sooklal, Selisha A.
    Malindisa, Sibusiso T.
    Daka, Lembelani Jonathan
    Ntwasa, Monde
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [25] Antibody mediated blockade of phosphatidylserine improves immune checkpoint blockade by repolarizing immune suppressive mechanisms of the tumor microenvironment
    Hutchins, J.
    ANNALS OF ONCOLOGY, 2016, 27
  • [26] Integrative tumor and immune cell multi-omic analyses to predict melanoma response to immune checkpoint blockade.
    Anagnostou, Valsamo
    Bruhm, Daniel C.
    Niknafs, Noushin
    White, James R.
    Sidhom, John-William
    Stein, Julie E.
    Tsai, Hua-Ling
    Wang, Hao
    Belcaid, Zineb
    Murray, Joseph Christopher
    Ross-Macdonald, Petra B.
    Wind-Rotolo, Megan
    Baras, Alexander S.
    Taube, Janis M.
    Scharpf, Robert B.
    Grasso, Catherine
    Ribas, Antoni
    Pardoll, Drew M.
    Topalian, Suzanne Louise
    Velculescu, Victor E.
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [27] Targeting the tumor microenvironment to overcome immune checkpoint blockade therapy resistance
    Li, Yaqi
    Liu, Jing
    Gao, Long
    Liu, Yuan
    Meng, Fang
    Li, Xiaoan
    Qin, F. Xiao-Feng
    IMMUNOLOGY LETTERS, 2020, 220 : 88 - 96
  • [28] Immune checkpoint blockade for lung cancer: state of the art
    Patel, Sandip Pravin
    TRANSLATIONAL CANCER RESEARCH, 2015, 4 (04) : 415 - 422
  • [29] Immune checkpoint blockade in small cell lung cancer
    Tay, Rebecca Y.
    Heigener, David
    Reck, Martin
    Califano, Raffaele
    LUNG CANCER, 2019, 137 : 31 - 37
  • [30] Immune checkpoint blockade reprograms tumor microenvironment and systemic immune landscape in obesity associated triple negative breast cancer
    Pingili, Ajeeth K.
    Chaib, Mehdi
    Sipe, Laura M.
    Miller, Emily J.
    Teng, Bin
    Sharma, Rahul
    Al Abdallah, Qusai
    Daria, Deidra
    Sekhri, Radhika
    Jo, Heejoon
    Tahliyah, Mims S.
    Hayes, D. Neil
    Pierre, Joseph F.
    Makowski, Liza
    CANCER RESEARCH, 2021, 81 (04)
12345